Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											149.120449485										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=DHHVAGZRUROJKS-UHFFFAOYSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											2-methyl-1-phenylpropan-2-amine										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											phentermine										
									 
																											
									
																		
										
											SMILES 
										
										
											CC(C)(N)CC1=CC=CC=C1										
									 
																		
																		
									
																		
																		
																		
																		
																		
																											
																		
																											
																		
																											
																		
																		
										
											pKa (Strongest Basic) 
										
										
											10.25										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											48.34 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Phentermine is indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction. Phentermine hydrochloride is a sympathomimetic amine with pharmacologic activity similar to the prototype drugs of this class used in obesity, the amphetamines. Actions include central nervous system stimulation and elevation of blood pressure. Tachyphylaxis and tolerance have been demonstrated with all drugs of this class in which these phenomena have been looked for.									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									A central nervous system stimulant and sympathomimetic with actions and uses similar to those of dextroamphetamine. It has been used most frequently in the treatment of obesity. [PubChem]. Some common brand names for phentermine are Adipex-P® and Suprenza™. Phentermine is also available in combination medications such as Qsymia®.								
								
									Phentermine is an amphetamine that stimulates neurons to release or maintain high levels of a particular group of neurotransmitters known as catecholamines; these include dopamine and norepinephrine. High levels of these catecholamines tend to suppress hunger signals and appetite. The drug seems to inhibit reuptake of noradrenaline, dopamine, and seratonin through inhibition or reversal of the reuptake transporters. It may also inhibit MAO enzymes leaving more neurotransmitter available at the synapse.Phentermine (through catecholamine elevation) may also indirectly affect leptin levels in the brain. It is theorized that phentermine can raise levels of leptin which signal satiety. It is also theorized that increased levels of the catecholamines are partially responsible for halting another chemical messenger known as neuropeptide Y. This peptide initiates eating, decreases energy expenditure, and increases fat storage.								
							
														
															
								 Dược Động Học  : 
								
									▧ Absorption : 
Phentermine is rapidly absorbed after oral ingestion.
▧ Protein binding : 
Approximately 96.3%
▧ Metabolism : 
Hepatic.
▧ Half Life : 
16 to 31 hours								
	
							 
														
														
								 Độc Tính : 
								
									LD50 is adult monkeys is 15 to 20 mg/kg. Symptoms of overdose include delirium, mania, self-injury, marked hypertension, tachycardia, arrhythmia, hyperpyrexia, convulsion, coma, and circulatory collapse.									
							
														
							
																					
								 Chỉ Định : 
								
									For the treatment and management of obesity.								
							
	
														
									
							
							
								 Tương Tác Thuốc : 
																
																		
									- 
										Acetophenazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Alimemazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Chlorpromazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Ethopropazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Fluoxetine
										
											Risk of serotoninergic syndrome										
									
- 
										Fluphenazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Fluvoxamine
										
											Risk of serotoninergic syndrome										
									
- 
										Guanethidine
										
											Phentermine may decrease the effect of guanethidine.										
									
- 
										Isocarboxazid
										
											Possible hypertensive crisis										
									
- 
										Mesoridazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Methdilazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Methotrimeprazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Paroxetine
										
											Risk of serotoninergic syndrome										
									
- 
										Perphenazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Phenelzine
										
											Possible hypertensive crisis										
									
- 
										Prochlorperazine
										
											Decreased anorexic effect, may increase psychotic symptoms.										
									
- 
										Promazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Promethazine
										
											Decreased anorexic effect, may increase psychotic symptoms.										
									
- 
										Propericiazine
										
											Decreased anorexic effect, may increase psychotic symptoms.										
									
- 
										Propiomazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Rasagiline
										
											Possible hypertensive crisis										
									
- 
										Thiethylperazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Thioridazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Tramadol
										
											Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome.										
									
- 
										Trandolapril
										
											Phentermine may reduce the efficacy of Trandolapril. 										
									
- 
										Tranylcypromine
										
											The MAO inhibitor, tranylcypromine, may increase the vasopressor effect of the amphetamine, phentermine. Concomitant therapy should be avoided.										
									
- 
										Trifluoperazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Triflupromazine
										
											Decreased anorexic effect, may increase psychotic symptoms										
									
- 
										Triprolidine
										
											Triprolidine may reduce the sedative effect of the antihistamine, Phentermine.										
									
- 
										Venlafaxine
										
											Risk of serotoninergic syndrome										
									
 								
							
							
							
							
								
								 Liều Lượng & Cách Dùng : 
								
									Capsule - Oral
Capsule - Oral - 11.25 mg/69 mg (PHENTERMINE HYDROCHLORIDE/ TOPIRAMATE ER)
Capsule - Oral - 15 mg/92 mg (PHENTERMINE HYDROCHLORIDE/ TOPIRAMATE ER)
Capsule - Oral - 3.75 mg/23 mg (PHENTERMINE HYDROCHLORIDE/ TOPIRAMATE ER)
Capsule - Oral - 7.5 mg/46 mg (PHENTERMINE HYDROCHLORIDE/ TOPIRAMATE ER) 								
							
	
							
														
														
							
																						
								 Dữ Kiện Thương Mại 
								
																											
																		
																											
										
											Nhà Sản Xuất
										
										
											
																							- 
													
													Sản phẩm biệt dược : Adipex-P 
- 
													
													Sản phẩm biệt dược : Duromine 
- 
													
													Sản phẩm biệt dược : Fastin 
- 
													
													Sản phẩm biệt dược : Ionamin 
- 
													
													Sản phẩm biệt dược : Obenix 
- 
													
													Sản phẩm biệt dược : Obestin-30 
- 
													
													Sản phẩm biệt dược : Phentercot 
- 
													
													Sản phẩm biệt dược : Phentride 
- 
													
													Sản phẩm biệt dược : Pro-Fast 
- 
													
													Sản phẩm biệt dược : Suprenza 
- 
													
													Sản phẩm biệt dược : Teramine 
- 
													
													Sản phẩm biệt dược : Zantryl 
 
									 
																		
																											
											  
		  
								 
							 	
							
							
														
							
						
							
																													
								 Tài Liệu Tham Khảo Thêm 
								
																		
																		
																		
																		
																		
																		
																		
										
											National Drug Code Directory